Vistin Pharma ASA (OSE: VISTIN), a producer of high quality API's and Solid Dosage Forms for the international pharmaceutical industry, will release its first quarter 2016 results on Thursday 28 April 2016.
The results will be presented by Vistin Pharma's CEO Kjell-Erik Nordby and CFO Gunnar Manum at 08:30 CET at Felix Konferansesenter, Bryggetorget 3, Oslo, Norway. Following the presentation, there will be a Q&A session. The presentation will be held in English.
The presentation will be webcast live and can be accessed directly from
or http://www.vistin.com/investors/webcast-article214-455.html .
The quarterly report and the presentation material will be available on www.vistin.com/investors and www.newsweb.no, as well as on news wires.
Vistin Pharma welcomes all interested parties.
For further information, please contact:
+47 95 17 91 90